By Professor Mark Duncan Willcox

Journal articles

Patel HP; Patel PJ; Patel BV; Patel RV; Desai DT; Vyas BA; Willcox MDP; Maulvi FA, 2024, 'Enhancing the bioavailability of clozapine through microwave-assisted formulation of a stable β-cyclodextrin inclusion complex', Colloids and Surfaces A: Physicochemical and Engineering Aspects, 690, http://dx.doi.org/10.1016/j.colsurfa.2024.133786

Maulvi FA; Parmar MB; Shetty KH; Patel AR; Desai BV; Vyas BA; Desai DT; Kalaiselvan P; Masoudi S; Shah DO; Willcox MDP, 2024, 'Role of micelle dynamics in enhancing cyclosporine uptake in hyaluronic acid-contact lenses for improved critical lens properties in dry eye management', Colloids and Surfaces A: Physicochemical and Engineering Aspects, 688, http://dx.doi.org/10.1016/j.colsurfa.2024.133550

Patel HP; Desai PH; Patel RV; Lodha SN; Gore AH; Patil PO; Desai BV; Desai DT; Vyas BA; Willcox MDP; Maulvi FA, 2024, 'Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies', Colloids and Surfaces B: Biointerfaces, 237, http://dx.doi.org/10.1016/j.colsurfb.2024.113862

Kruse HV; Chakraborty S; Chen R; Kumar N; Yasir M; Lewin WT; Suchowerska N; Willcox MDP; McKenzie DR, 2024, 'Protecting Orthopaedic Implants from Infection: Antimicrobial Peptide Mel4 Is Non-Toxic to Bone Cells and Reduces Bacterial Colonisation When Bound to Plasma Ion-Implanted 3D-Printed PAEK Polymers', Cells, 13, pp. 656 - 656, http://dx.doi.org/10.3390/cells13080656

Sara M; Yasir M; Kalaiselvan P; Hui A; Kuppusamy R; Kumar N; Chakraborty S; Yu TT; Wong EHH; Molchanova N; Jenssen H; Lin JS; Barron AE; Willcox M, 2024, 'The activity of antimicrobial peptoids against multidrug-resistant ocular pathogens', Contact Lens and Anterior Eye, 47, http://dx.doi.org/10.1016/j.clae.2024.102124

Ilyas M; Stapleton F; Willcox MDP; Henriquez F; Peguda HK; Rayamajhee B; Zahid T; Petsoglou C; Carnt NA, 2024, 'Epidemiology of and Genetic Factors Associated with Acanthamoeba Keratitis', Pathogens, 13, http://dx.doi.org/10.3390/pathogens13020142

Yasir M; Willcox MDP, 2024, 'The use of ultraviolet light generated from light-emitting diodes for the disinfection of transvaginal ultrasound probes', PLoS ONE, 19, http://dx.doi.org/10.1371/journal.pone.0298449

Maulvi FA; Patel AR; Shetty KH; Desai DT; Shah DO; Willcox MDP, 2024, 'Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma', Drug Delivery and Translational Research, http://dx.doi.org/10.1007/s13346-024-01543-8

Maulvi FA; Desai DT; Kalaiselvan P; Dumpati S; Kuppusamy R; Masoudi S; Shah DO; Willcox MDP, 2024, 'Lipid-based eye drop formulations for the management of evaporative dry eyes', Contact Lens and Anterior Eye, http://dx.doi.org/10.1016/j.clae.2024.102154

Enninful GN; Kuppusamy R; Tiburu EK; Kumar N; Willcox MDP, 2024, 'Non-canonical amino acid bioincorporation into antimicrobial peptides and its challenges', Journal of Peptide Science, http://dx.doi.org/10.1002/psc.3560

Rayamajhee B; Willcox M; Henriquez FL; Vijay AK; Petsoglou C; Shrestha GS; Peguda HK; Carnt N, 2024, 'The role of naturally acquired intracellular Pseudomonas aeruginosa in the development of Acanthamoeba keratitis in an animal model', PLoS Neglected Tropical Diseases, 18, http://dx.doi.org/10.1371/journal.pntd.0011878

Rayamajhee B; Willcox M; Sharma S; Mooney R; Petsoglou C; Badenoch PR; Sherchan S; Henriquez FL; Carnt N, 2024, 'Zooming in on the intracellular microbiome composition of bacterivorous Acanthamoeba isolates.', ISME Commun, 4, pp. ycae016, http://dx.doi.org/10.1093/ismeco/ycae016

Rayamajhee B; Williams NLR; Siboni N; Rodgers K; Willcox M; Henriquez FL; Seymour JR; Potts J; Johnson C; Scanes P; Carnt N, 2023, 'Identification and quantification of Acanthamoeba spp. within seawater at four coastal lagoons on the east coast of Australia', Science of the Total Environment, 901, http://dx.doi.org/10.1016/j.scitotenv.2023.165862

Shahzad S; Willcox MDP; Rayamajhee B, 2023, 'A Review of Resistance to Polymyxins and Evolving Mobile Colistin Resistance Gene (mcr) among Pathogens of Clinical Significance', Antibiotics, 12, http://dx.doi.org/10.3390/antibiotics12111597

Shao Z; Hakobyan K; Xu J; Chen R; Kumar N; Willcox M; Wong EHH, 2023, 'Photoinduced Unveiling of Cationic Amine: Toward Smart Photoresponsive Antimicrobial Polymers', ACS Applied Polymer Materials, 5, pp. 8735 - 8743, http://dx.doi.org/10.1021/acsapm.3c01904

Browne K; Kuppusamy R; Walsh WR; Black DSC; Willcox MDP; Kumar N; Chen R, 2023, 'Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria', International Journal of Molecular Sciences, 24, http://dx.doi.org/10.3390/ijms241914966

Duong HT; Phan MAT; Madigan MC; Stapleton F; Wilcsek G; Willcox M; Golebiowski B, 2023, 'Culture of primary human meibomian gland cells from surgically excised eyelid tissue', Experimental Eye Research, 235, pp. 109636, http://dx.doi.org/10.1016/j.exer.2023.109636

Ozkan J; Majzoub ME; Coroneo M; Thomas T; Willcox M, 2023, 'Ocular microbiome changes in dry eye disease and meibomian gland dysfunction', Experimental Eye Research, 235, http://dx.doi.org/10.1016/j.exer.2023.109615

Craig JP; Alves M; Wolffsohn JS; Downie LE; Efron N; Galor A; Gomes JAP; Jones L; Markoulli M; Stapleton F; Starr CE; Sullivan AG; Willcox MDP; Sullivan DA, 2023, 'TFOS Lifestyle Report Executive Summary: A Lifestyle Epidemic - Ocular Surface Disease', Ocular Surface, 30, pp. 240 - 253, http://dx.doi.org/10.1016/j.jtos.2023.08.009

Urmi UL; Attard S; Vijay AK; Willcox MDP; Kumar N; Islam S; Kuppusamy R, 2023, 'Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus', Antibiotics, 12, pp. 1436, http://dx.doi.org/10.3390/antibiotics12091436

Urmi UL; Vijay AK; Kuppusamy R; Islam S; Willcox MDP, 2023, 'A review of the antiviral activity of cationic antimicrobial peptides', Peptides, 166, http://dx.doi.org/10.1016/j.peptides.2023.171024

Mishra SK; Yasir M; Willcox M; Mishra Baishnab SK, 2023, 'Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern', The Lancet Microbe, 4, pp. e482 - e483, http://dx.doi.org/10.1016/S2666-5247(23)00114-3

Chakraborty S; Katsifis G; Roohani I; Boyer C; McKenzie D; Willcox MDP; Chen R; Kumar N, 2023, 'Electrostatic and Covalent Binding of an Antibacterial Polymer to Hydroxyapatite for Protection against Escherichia coli Colonization', Materials, 16, pp. 5045, http://dx.doi.org/10.3390/ma16145045

Cappiello F; Verma S; Lin X; Moreno IY; Casciaro B; Dutta D; McDermott AM; Willcox M; Coulson-Thomas VJ; Mangoni ML, 2023, 'Novel Peptides with Dual Properties for Treating Pseudomonas aeruginosa Keratitis: Antibacterial and Corneal Wound Healing', Biomolecules, 13, pp. 1028, http://dx.doi.org/10.3390/biom13071028

Jones L; Efron N; Bandamwar K; Barnett M; Jacobs DS; Jalbert I; Pult H; Rhee MK; Sheardown H; Shovlin JP; Stahl U; Stanila A; Tan J; Tavazzi S; Ucakhan OO; Willcox MDP; Downie LE, 2023, 'TFOS Lifestyle: Impact of contact lenses on the ocular surface', Ocular Surface, 29, pp. 175 - 219, http://dx.doi.org/10.1016/j.jtos.2023.04.010

Gomes JAP; Azar DT; Baudouin C; Bitton E; Chen W; Hafezi F; Hamrah P; Hogg RE; Horwath-Winter J; Kontadakis GA; Mehta JS; Messmer EM; Perez VL; Zadok D; Willcox MDP, 2023, 'TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface', Ocular Surface, 29, pp. 331 - 385, http://dx.doi.org/10.1016/j.jtos.2023.04.011

Markoulli M; Ahmad S; Arcot J; Arita R; Benitez-del-Castillo J; Caffery B; Downie LE; Edwards K; Flanagan J; Labetoulle M; Misra SL; Mrugacz M; Singh S; Sheppard J; Vehof J; Versura P; Willcox MDP; Ziemanski J; Wolffsohn JS, 2023, 'TFOS Lifestyle: Impact of nutrition on the ocular surface: TFOS Lifestyle Workshop: Nutrition report', Ocular Surface, 29, pp. 226 - 271, http://dx.doi.org/10.1016/j.jtos.2023.04.003

Khan M; Ma K; Wan I; Willcox MD, 2023, 'Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates', Contact Lens and Anterior Eye, 46, pp. 101819, http://dx.doi.org/10.1016/j.clae.2023.101819

Urmi UL; Willcox MDP; Islam S; Kuppusamy R; Vijay AK, 2023, 'Ocular signs and symptoms of monkeypox virus infection, and possible role of the eye in transmission of the virus', Contact Lens and Anterior Eye, 46, pp. 101808, http://dx.doi.org/10.1016/j.clae.2022.101808

Craig JP; Alves M; Wolffsohn JS; Downie LE; Efron N; Galor A; Gomes JAP; Jones L; Markoulli M; Stapleton F; Starr CE; Sullivan AG; Willcox MDP; Sullivan DA, 2023, 'TFOS Lifestyle Report Introduction: A Lifestyle Epidemic - Ocular Surface Disease', Ocular Surface, 28, pp. 304 - 309, http://dx.doi.org/10.1016/j.jtos.2023.04.014

Perez VL; Mah FS; Willcox M; Pflugfelder S, 2023, 'Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review', Journal of Ocular Pharmacology and Therapeutics, 39, pp. 89 - 101, http://dx.doi.org/10.1089/jop.2022.0133

Peguda HK; Lakshminarayanan R; Carnt NA; Gu Z; Willcox MDP, 2023, 'Correction to: The Activity of Polyhomoarginine against Acanthamoeba castellanii (Biology, (2022), 11, 12, (1726), 10.3390/biology11121726)', Biology, 12, pp. 470, http://dx.doi.org/10.3390/biology12030470

Kuppusamy R; Yasir M; Yu TT; Voli F; Vittorio O; Miller MJ; Lewis P; Black DSC; Willcox M; Kumar N, 2023, 'Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm', Antibiotics, 12, pp. 585, http://dx.doi.org/10.3390/antibiotics12030585

Dahal A; Shrestha K; Karki R; Bhattarai S; Aryal S; Deo SK; Regmi B; Willcox M; Mishra SK, 2023, 'Antimicrobial Resistance and Biofilm Production in Uropathogens from Renal Disease Patients Admitted to Tribhuvan University Teaching Hospital, Nepal', Journal of Clinical Pharmacy and Therapeutics, 2023, http://dx.doi.org/10.1155/2023/4867817

Das T; Das B; Young BC; Aldilla V; Sabir S; Almohaywi B; Willcox M; Manefield M; Kumar N, 2023, 'Ascorbic acid modulates the structure of the Pseudomonas aeruginosa virulence factor pyocyanin and ascorbic acid-furanone-30 combination facilitate biofilm disruption', Frontiers in Microbiology, 14, pp. 1166607, http://dx.doi.org/10.3389/fmicb.2023.1166607

Willcox MDP; Bahatheg G; Carnt N; Kalaiselvan P; Kumar N; Kuppusamy R; Rayamajhee B; Sara M; Stapleton F; Vijay AK; Yasir M; Yu TT, 2023, 'Biofilms and contact lenses: problems and solutions', Microbiology Australia, 44, pp. 96 - 99, http://dx.doi.org/10.1071/MA23027

Subedi D; Fang T; Bhusal RP; Willcox M, 2023, 'Editorial: Bacteriophages to treat infections with multidrug resistant pathogens', Frontiers in Medicine, 10, http://dx.doi.org/10.3389/fmed.2023.1348463

Kalaiselvan P; Dutta D; Konda NV; Sharma S; Kumar N; Stapleton F; Willcox MDP, 2023, 'Effect of Deposition and Protease Digestion on the Ex Vivo Activity of Antimicrobial Peptide-Coated Contact Lenses', Nanomaterials, 13, pp. 349, http://dx.doi.org/10.3390/nano13020349

Kalaiselvan P; Yasir M; Vijay AK; Willcox MDP; Tummanapalli S, 2023, 'Longevity of hand sanitisers on fingers', Clinical and Experimental Optometry, 106, pp. 436 - 442, http://dx.doi.org/10.1080/08164622.2022.2040334

Sabir S; Das T; Kuppusamy R; Yu TT; Willcox MD; Black DSC; Kumar N, 2023, 'Novel quinazolinone disulfide analogues as pqs quorum sensing inhibitors against Pseudomonas aeruginosa', Bioorganic Chemistry, 130, pp. 106226, http://dx.doi.org/10.1016/j.bioorg.2022.106226

Kuppusamy R; Browne K; Suresh D; Do Rosario RM; Chakraborty S; Yang S; Willcox M; Black D; Chen R; Kumar N, 2023, 'Transition Towards Antibiotic Hybrid Vehicles: The Next Generation Antibacterials', Current Medicinal Chemistry, 30, pp. 104 - 125, http://dx.doi.org/10.2174/0929867329666220613105424

Rayamajhee B; Sharma S; Willcox M; Henriquez FL; Rajagopal RN; Shrestha GS; Subedi D; Bagga B; Carnt N, 2022, 'Assessment of genotypes, endosymbionts and clinical characteristics of Acanthamoeba recovered from ocular infection', BMC Infectious Diseases, 22, pp. 757, http://dx.doi.org/10.1186/s12879-022-07741-4

Aldilla VR; Chen R; Kuppusamy R; Chakraborty S; Willcox MDP; Black DSC; Thordarson P; Martin AD; Kumar N, 2022, 'Hydrogels with intrinsic antibacterial activity prepared from naphthyl anthranilamide (NaA) capped peptide mimics', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-26426-1

Peguda HK; Lakshminarayanan R; Carnt NA; Gu Z; Willcox MDP, 2022, 'The Activity of Polyhomoarginine against Acanthamoeba castellanii', Biology, 11, pp. 1726, http://dx.doi.org/10.3390/biology11121726

Peguda HK; Carnt NA; Gu Z; Kumar N; Willcox MDP; Kuppusamy R, 2022, 'The Anti-Amoebic Activity of a Peptidomimetic against Acanthamoeba castellanii', Microorganisms, 10, pp. 2377, http://dx.doi.org/10.3390/microorganisms10122377

Rayamajhee B; Willcox MDP; Henriquez FL; Petsoglou C; Subedi D; Carnt N, 2022, 'Acanthamoeba, an environmental phagocyte enhancing survival and transmission of human pathogens', Trends in Parasitology, 38, pp. 975 - 990, http://dx.doi.org/10.1016/j.pt.2022.08.007

Konda N; Chakrabarti S; Garg P; Willcox MDP, 2022, 'Association of Single-Nucleotide Polymorphisms in Interleukin Genes with Microbial Keratitis in a South Indian Population', Pathogens, 11, pp. 1387, http://dx.doi.org/10.3390/pathogens11111387

Dutta D; Stapleton F; Willcox M, 2022, 'Ocular Surface Infection and Antimicrobials', Antibiotics, 11, pp. 1496, http://dx.doi.org/10.3390/antibiotics11111496

Afzal M; Vijay AK; Stapleton F; Willcox M, 2022, 'The Relationship between Ciprofloxacin Resistance and Genotypic Changes in S. aureus Ocular Isolates', Pathogens, 11, pp. 1354, http://dx.doi.org/10.3390/pathogens11111354

Cometta S; Jones RT; Juárez-Saldivar A; Donose BC; Yasir M; Bock N; Dargaville TR; Bertling K; Brünig M; Rakić AD; Willcox M; Hutmacher DW, 2022, 'Melimine-Modified 3D-Printed Polycaprolactone Scaffolds for the Prevention of Biofilm-Related Biomaterial Infections', ACS Nano, 16, pp. 16497 - 16512, http://dx.doi.org/10.1021/acsnano.2c05812

Back to profile page